APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Surgical Hemostatic Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Surgical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174038810319 December 2025195 pages

Choose your research edition.

Industry ResearchSurgical Hemostatic Agents Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Surgical Hemostatic Agents Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Surgical Hemostatic Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Surgical Hemostatic Agents Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Surgical Hemostatic Agents Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Surgical Hemostatic Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Surgical Hemostatic Agents include J&J, Advance Medical Solution, B Braun, BD, CryoLife, CSL Behring, Equimedical, Ferrosan Medical Devices and Gelita, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Surgical Hemostatic Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Surgical Hemostatic Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Surgical Hemostatic Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Surgical Hemostatic Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Surgical Hemostatic Agents Segment by Company

J&J

Advance Medical Solution

B Braun

BD

CryoLife

CSL Behring

Equimedical

Ferrosan Medical Devices

Gelita

Marine Polymer

Z-Medica

Baxter

Pfizer

Medtronic

Surgical Hemostatic Agents Segment by Type

Gelation Hemostats

Combination Hemostats

Others

Surgical Hemostatic Agents Segment by Application

Hospitals

Surgical Centers

Other

Surgical Hemostatic Agents Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surgical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Surgical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surgical Hemostatic Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Surgical Hemostatic Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Surgical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Surgical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Surgical Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Surgical Hemostatic Agents Industry Trends Table 2. Surgical Hemostatic Agents Industry Drivers Table 3. Surgical Hemostatic Agents Industry Opportunities and Challenges Table 4. Surgical Hemostatic Agents Industry Restraints Table 5. Global Surgical Hemostatic Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Surgical Hemostatic Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Surgical Hemostatic Agents Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Surgical Hemostatic Agents Sales Market Share by Manufacturers Table 9. Global Surgical Hemostatic Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Surgical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Surgical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Surgical Hemostatic Agents Manufacturers, Product Type & Application Table 13. Global Surgical Hemostatic Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Surgical Hemostatic Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gelation Hemostats Table 17. Major Manufacturers of Combination Hemostats Table 18. Major Manufacturers of Others Table 19. Global Surgical Hemostatic Agents Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Surgical Hemostatic Agents Sales by Type (2021-2026) & (K Units) Table 21. Global Surgical Hemostatic Agents Sales by Type (2027-2032) & (K Units) Table 22. Global Surgical Hemostatic Agents Sales Market Share by Type (2021-2026) Table 23. Global Surgical Hemostatic Agents Sales Market Share by Type (2027-2032) Table 24. Global Surgical Hemostatic Agents Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Surgical Hemostatic Agents Revenue by Type (2021-2026) & (K Units) Table 26. Global Surgical Hemostatic Agents Revenue by Type (2027-2032) & (K Units) Table 27. Global Surgical Hemostatic Agents Revenue Market Share by Type (2021-2026) Table 28. Global Surgical Hemostatic Agents Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Surgical Centers Table 31. Major Manufacturers of Other Table 32. Global Surgical Hemostatic Agents Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Surgical Hemostatic Agents Sales by Application (2021-2026) & (K Units) Table 34. Global Surgical Hemostatic Agents Sales by Application (2027-2032) & (K Units) Table 35. Global Surgical Hemostatic Agents Sales Market Share by Application (2021-2026) Table 36. Global Surgical Hemostatic Agents Sales Market Share by Application (2027-2032) Table 37. Global Surgical Hemostatic Agents Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Surgical Hemostatic Agents Revenue by Application (2021-2026) & (K Units) Table 39. Global Surgical Hemostatic Agents Revenue by Application (2027-2032) & (K Units) Table 40. Global Surgical Hemostatic Agents Revenue Market Share by Application (2021-2026) Table 41. Global Surgical Hemostatic Agents Revenue Market Share by Application (2027-2032) Table 42. Global Surgical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Surgical Hemostatic Agents Sales by Region (2021-2026) & (K Units) Table 44. Global Surgical Hemostatic Agents Sales Market Share by Region (2021-2026) Table 45. Global Surgical Hemostatic Agents Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Surgical Hemostatic Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 49. North America Surgical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 50. Europe Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 52. Europe Surgical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Surgical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Surgical Hemostatic Agents Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Surgical Hemostatic Agents Sales by Country (2027-2032) & (K Units) Table 59. Global Surgical Hemostatic Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Surgical Hemostatic Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Surgical Hemostatic Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Surgical Hemostatic Agents Revenue Market Share by Region (2021-2026) Table 63. Global Surgical Hemostatic Agents Revenue Market Share by Region (2027-2032) Table 64. J&J Company Information Table 65. J&J Business Overview Table 66. J&J Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. J&J Surgical Hemostatic Agents Product Portfolio Table 68. J&J Recent Development Table 69. Advance Medical Solution Company Information Table 70. Advance Medical Solution Business Overview Table 71. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Advance Medical Solution Surgical Hemostatic Agents Product Portfolio Table 73. Advance Medical Solution Recent Development Table 74. B Braun Company Information Table 75. B Braun Business Overview Table 76. B Braun Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. B Braun Surgical Hemostatic Agents Product Portfolio Table 78. B Braun Recent Development Table 79. BD Company Information Table 80. BD Business Overview Table 81. BD Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BD Surgical Hemostatic Agents Product Portfolio Table 83. BD Recent Development Table 84. CryoLife Company Information Table 85. CryoLife Business Overview Table 86. CryoLife Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. CryoLife Surgical Hemostatic Agents Product Portfolio Table 88. CryoLife Recent Development Table 89. CSL Behring Company Information Table 90. CSL Behring Business Overview Table 91. CSL Behring Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. CSL Behring Surgical Hemostatic Agents Product Portfolio Table 93. CSL Behring Recent Development Table 94. Equimedical Company Information Table 95. Equimedical Business Overview Table 96. Equimedical Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Equimedical Surgical Hemostatic Agents Product Portfolio Table 98. Equimedical Recent Development Table 99. Ferrosan Medical Devices Company Information Table 100. Ferrosan Medical Devices Business Overview Table 101. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio Table 103. Ferrosan Medical Devices Recent Development Table 104. Gelita Company Information Table 105. Gelita Business Overview Table 106. Gelita Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Gelita Surgical Hemostatic Agents Product Portfolio Table 108. Gelita Recent Development Table 109. Marine Polymer Company Information Table 110. Marine Polymer Business Overview Table 111. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Marine Polymer Surgical Hemostatic Agents Product Portfolio Table 113. Marine Polymer Recent Development Table 114. Z-Medica Company Information Table 115. Z-Medica Business Overview Table 116. Z-Medica Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Z-Medica Surgical Hemostatic Agents Product Portfolio Table 118. Z-Medica Recent Development Table 119. Baxter Company Information Table 120. Baxter Business Overview Table 121. Baxter Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Baxter Surgical Hemostatic Agents Product Portfolio Table 123. Baxter Recent Development Table 124. Pfizer Company Information Table 125. Pfizer Business Overview Table 126. Pfizer Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Pfizer Surgical Hemostatic Agents Product Portfolio Table 128. Pfizer Recent Development Table 129. Medtronic Company Information Table 130. Medtronic Business Overview Table 131. Medtronic Surgical Hemostatic Agents Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Medtronic Surgical Hemostatic Agents Product Portfolio Table 133. Medtronic Recent Development Table 134. Key Raw Materials Table 135. Raw Materials Key Suppliers Table 136. Surgical Hemostatic Agents Distributors List Table 137. Surgical Hemostatic Agents Customers List Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Surgical Hemostatic Agents Product Image Figure 2. Global Surgical Hemostatic Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Surgical Hemostatic Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Surgical Hemostatic Agents Sales (2021-2032) & (K Units) Figure 5. Global Surgical Hemostatic Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Surgical Hemostatic Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gelation Hemostats Image Figure 9. Combination Hemostats Image Figure 10. Others Image Figure 11. Global Surgical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Surgical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Surgical Hemostatic Agents Sales Market Share by Type (2021-2032) Figure 14. Global Surgical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Surgical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Surgical Hemostatic Agents Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Surgical Centers Image Figure 19. Other Image Figure 20. Global Surgical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Surgical Hemostatic Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Surgical Hemostatic Agents Sales Market Share by Application (2021-2032) Figure 23. Global Surgical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Surgical Hemostatic Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Surgical Hemostatic Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Surgical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Surgical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 40. China Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Surgical Hemostatic Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Surgical Hemostatic Agents Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Surgical Hemostatic Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Surgical Hemostatic Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Surgical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Surgical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Surgical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Surgical Hemostatic Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Surgical Hemostatic Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Surgical Hemostatic Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gelation Hemostats
  • Combination Hemostats
  • Others
Applications
  • Hospitals
  • Surgical Centers
  • Other
Companies covered
  • J&J
  • Advance Medical Solution
  • B Braun
  • BD
  • CryoLife
  • CSL Behring
  • Equimedical
  • Ferrosan Medical Devices
  • Gelita
  • Marine Polymer
  • Z-Medica
  • Baxter
  • Pfizer
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Surgical Hemostatic Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Surgical Hemostatic Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Surgical Hemostatic Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Surgical Hemostatic Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Surgical Hemostatic Agents Market Dynamics
  1. 2.1 Surgical Hemostatic Agents Industry Trends
  2. 2.2 Surgical Hemostatic Agents Industry Drivers
  3. 2.3 Surgical Hemostatic Agents Industry Opportunities and Challenges
  4. 2.4 Surgical Hemostatic Agents Industry Restraints
3 Surgical Hemostatic Agents Market by Manufacturers
  1. 3.1 Global Surgical Hemostatic Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Surgical Hemostatic Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Surgical Hemostatic Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Surgical Hemostatic Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Surgical Hemostatic Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Surgical Hemostatic Agents Manufacturers, Product Type & Application
  7. 3.7 Global Surgical Hemostatic Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Surgical Hemostatic Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Surgical Hemostatic Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Surgical Hemostatic Agents Tier 1, Tier 2, and Tier 3
4 Surgical Hemostatic Agents Market by Type
  1. 4.1 Surgical Hemostatic Agents Type Introduction
  2. 4.1.1 Gelation Hemostats
  3. 4.1.2 Combination Hemostats
  4. 4.1.3 Others
  5. 4.2 Global Surgical Hemostatic Agents Sales by Type
  6. 4.2.1 Global Surgical Hemostatic Agents Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Surgical Hemostatic Agents Sales by Type (2021-2032)
  8. 4.2.3 Global Surgical Hemostatic Agents Sales Market Share by Type (2021-2032)
  9. 4.3 Global Surgical Hemostatic Agents Revenue by Type
  10. 4.3.1 Global Surgical Hemostatic Agents Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Surgical Hemostatic Agents Revenue by Type (2021-2032)
  12. 4.3.3 Global Surgical Hemostatic Agents Revenue Market Share by Type (2021-2032)
5 Surgical Hemostatic Agents Market by Application
  1. 5.1 Surgical Hemostatic Agents Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Surgical Centers
  4. 5.1.3 Other
  5. 5.2 Global Surgical Hemostatic Agents Sales by Application
  6. 5.2.1 Global Surgical Hemostatic Agents Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Surgical Hemostatic Agents Sales by Application (2021-2032)
  8. 5.2.3 Global Surgical Hemostatic Agents Sales Market Share by Application (2021-2032)
  9. 5.3 Global Surgical Hemostatic Agents Revenue by Application
  10. 5.3.1 Global Surgical Hemostatic Agents Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Surgical Hemostatic Agents Revenue by Application (2021-2032)
  12. 5.3.3 Global Surgical Hemostatic Agents Revenue Market Share by Application (2021-2032)
6 Global Surgical Hemostatic Agents Sales by Region
  1. 6.1 Global Surgical Hemostatic Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Surgical Hemostatic Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Surgical Hemostatic Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Surgical Hemostatic Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Surgical Hemostatic Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Surgical Hemostatic Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Surgical Hemostatic Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Surgical Hemostatic Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Surgical Hemostatic Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Surgical Hemostatic Agents Revenue by Region
  1. 7.1 Global Surgical Hemostatic Agents Revenue by Region
  2. 7.1.1 Global Surgical Hemostatic Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Surgical Hemostatic Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Surgical Hemostatic Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Surgical Hemostatic Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Surgical Hemostatic Agents Revenue (2021-2032)
  8. 7.2.2 North America Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Surgical Hemostatic Agents Revenue (2021-2032)
  11. 7.3.2 Europe Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Surgical Hemostatic Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Surgical Hemostatic Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Surgical Hemostatic Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 J&J
  2. 8.1.1 J&J Company Information
  3. 8.1.2 J&J Business Overview
  4. 8.1.3 J&J Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 J&J Surgical Hemostatic Agents Product Portfolio
  6. 8.1.5 J&J Recent Developments
  7. 8.2 Advance Medical Solution
  8. 8.2.1 Advance Medical Solution Company Information
  9. 8.2.2 Advance Medical Solution Business Overview
  10. 8.2.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
  12. 8.2.5 Advance Medical Solution Recent Developments
  13. 8.3 B Braun
  14. 8.3.1 B Braun Company Information
  15. 8.3.2 B Braun Business Overview
  16. 8.3.3 B Braun Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B Braun Surgical Hemostatic Agents Product Portfolio
  18. 8.3.5 B Braun Recent Developments
  19. 8.4 BD
  20. 8.4.1 BD Company Information
  21. 8.4.2 BD Business Overview
  22. 8.4.3 BD Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BD Surgical Hemostatic Agents Product Portfolio
  24. 8.4.5 BD Recent Developments
  25. 8.5 CryoLife
  26. 8.5.1 CryoLife Company Information
  27. 8.5.2 CryoLife Business Overview
  28. 8.5.3 CryoLife Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CryoLife Surgical Hemostatic Agents Product Portfolio
  30. 8.5.5 CryoLife Recent Developments
  31. 8.6 CSL Behring
  32. 8.6.1 CSL Behring Company Information
  33. 8.6.2 CSL Behring Business Overview
  34. 8.6.3 CSL Behring Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
  36. 8.6.5 CSL Behring Recent Developments
  37. 8.7 Equimedical
  38. 8.7.1 Equimedical Company Information
  39. 8.7.2 Equimedical Business Overview
  40. 8.7.3 Equimedical Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Equimedical Surgical Hemostatic Agents Product Portfolio
  42. 8.7.5 Equimedical Recent Developments
  43. 8.8 Ferrosan Medical Devices
  44. 8.8.1 Ferrosan Medical Devices Company Information
  45. 8.8.2 Ferrosan Medical Devices Business Overview
  46. 8.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
  48. 8.8.5 Ferrosan Medical Devices Recent Developments
  49. 8.9 Gelita
  50. 8.9.1 Gelita Company Information
  51. 8.9.2 Gelita Business Overview
  52. 8.9.3 Gelita Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Gelita Surgical Hemostatic Agents Product Portfolio
  54. 8.9.5 Gelita Recent Developments
  55. 8.10 Marine Polymer
  56. 8.10.1 Marine Polymer Company Information
  57. 8.10.2 Marine Polymer Business Overview
  58. 8.10.3 Marine Polymer Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
  60. 8.10.5 Marine Polymer Recent Developments
  61. 8.11 Z-Medica
  62. 8.11.1 Z-Medica Company Information
  63. 8.11.2 Z-Medica Business Overview
  64. 8.11.3 Z-Medica Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
  66. 8.11.5 Z-Medica Recent Developments
  67. 8.12 Baxter
  68. 8.12.1 Baxter Company Information
  69. 8.12.2 Baxter Business Overview
  70. 8.12.3 Baxter Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Surgical Hemostatic Agents Product Portfolio
  72. 8.12.5 Baxter Recent Developments
  73. 8.13 Pfizer
  74. 8.13.1 Pfizer Company Information
  75. 8.13.2 Pfizer Business Overview
  76. 8.13.3 Pfizer Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pfizer Surgical Hemostatic Agents Product Portfolio
  78. 8.13.5 Pfizer Recent Developments
  79. 8.14 Medtronic
  80. 8.14.1 Medtronic Company Information
  81. 8.14.2 Medtronic Business Overview
  82. 8.14.3 Medtronic Surgical Hemostatic Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Medtronic Surgical Hemostatic Agents Product Portfolio
  84. 8.14.5 Medtronic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Surgical Hemostatic Agents Value Chain Analysis
  2. 9.1.1 Surgical Hemostatic Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Surgical Hemostatic Agents Production Mode & Process
  6. 9.2 Surgical Hemostatic Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Surgical Hemostatic Agents Distributors
  9. 9.2.3 Surgical Hemostatic Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst